Skip to main content

Table 1 Transgenic efficiency after injection of lentiviral vectors carrying the APPSw/Ind double mutation under control of the ubiquitin-C promoter in Fischer 344 rat zygotes.

From: Development of transgenic rats producing human β-amyloid precursor protein as a model for Alzheimer's disease: Transgene and endogenous APP genes are regulated tissue-specifically

Zygotes injected

Embryos transferred

Live pups born

Transgenic pups

Germline transgenic

168

156 (93%)

18 (12%)

4 (22%)

2 (50%)